Body may keep a dormant cancer in check - study

Key points
- Tumor cells found in the blood of breast cancer patients up to 20 years after surgery suggest that the body may have ways of keeping a dormant cancer in check, U.S. researchers said on Wednesday.
- One third of 36 former breast cancer patients were found to have the cells, according to the team at the University of Texas Southwestern at Dallas.
- The study, published in the journal Clinical Cancer Research, seems to show the body can maintain a balance between tumor cell proliferation and cell death.
- Some of the patients had undergone mastectomies 20 years before.
Tumor cells found in the blood of breast cancer patients up to 20 years after surgery suggest that the body may have ways of keeping a dormant cancer in check, U.S. researchers said on Wednesday.
One third of 36 former breast cancer patients were found to have the cells, according to the team at the University of Texas Southwestern at Dallas.
The study, published in the journal Clinical Cancer Research, seems to show the body can maintain a balance between tumor cell proliferation and cell death. People who stay cancer-free may have a system for keeping a tumor under control, the researchers said.
Some of the patients had undergone mastectomies 20 years before. Such people have a low rate of cancer recurrence, but after about 20 years the risk rises sharply to 20 percent - a condition called dormancy that doctors do not understand.
"Dormancy is a mysterious phenomenon that occurs in certain types of cancer," said Dr. Jonathan Uhr, who led the study.
His team collected blood from 36 patients who had been free of cancer for at least 7 years. Thirteen were found to have circulating tumor cells. Because these cells do not live long, Uhr said there must be tiny, unseen tumors somewhere in the body producing them.
Understanding how the body controls these tumors may offer new ways to treat and prevent cancer, he said.
"It is also important to determine what changes are responsible for relapse," Uhr said. "If patients at risk for impending relapse can be identified, it may be possible to prevent recurrence with appropriate therapy."
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsCancer rates in U.S. keep falling: American Cancer Society
Cancer death rates are continuing to fall, dropping by 1.8 percent per year in men and 1.6 percent per year in women between 2004 and 2008, according to the American Cancer Society's annual report on cancer statistics…
6 January 2012
NewsLow dose naltrexone (LDN): Harnessing the body's own chemistry to treat human ovarian cancer
Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that a low dose of the opioid antagonist naltrexone (LDN) has an extraordinarily potent antitumor effect on…
14 July 2011
NewsCancer cells accelerate aging and inflammation in the body to drive tumor growth
Researchers at the Kimmel Cancer Center at Jefferson have shed new light on the longstanding conundrum about what makes a tumor grow—and how to make it stop. Interestingly, cancer cells accelerate the aging of nearby…






